| Neuropeptide Y family of hormones: receptor subtypes and antagonists A Balasubramaniam Peptides 18 (3), 445-457, 1997 | 279 | 1997 |
| Anorexia following the intrahypothalamic administration of amylin WT Chance, A Balasubramaniam, FS Zhang, SJ Wimalawansa, ... Brain research 539 (2), 352-354, 1991 | 201 | 1991 |
| Effects of neuropeptide Y, NPY analog (norleucine4-NPY), galanin and neuropeptide K on LH release in ovariectomized (ovx) and ovx estrogen, progesterone-treated rats A Sahu, WR Crowley, K Tatemoto, A Balasubramaniam, SP Kalra Peptides 8 (5), 921-926, 1987 | 194 | 1987 |
| Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2 WT Chance, T Foley-Nelson, I Thomas, A Balasubramaniam American Journal of Physiology-Gastrointestinal and Liver Physiology 273 (2 …, 1997 | 180 | 1997 |
| Stimulation of both aerobic glycolysis and Na+-K+-ATPase activity in skeletal muscle by epinephrine or amylin JH James, KR Wagner, JK King, RE Leffler, RK Upputuri, ... American Journal of Physiology-Endocrinology And Metabolism 277 (1), E176-E186, 1999 | 169 | 1999 |
| GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists EM Parker, CK Babij, A Balasubramaniam, RE Burrier, M Guzzi, F Hamud, ... European journal of pharmacology 349 (1), 97-105, 1998 | 126 | 1998 |
| Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17] NPY), NPY analog ([norLeu4] NPY) and peptide YY JT Clark, A Sahu, PS Kalra, A Balasubramaniam, SP Kalra Regulatory peptides 17 (1), 31-39, 1987 | 124 | 1987 |
| Clinical potentials of neuropeptide Y family of hormones A Balasubramaniam The American journal of surgery 183 (4), 430-434, 2002 | 120 | 2002 |
| Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes A Balasubramaniam, S Sheriff, DF Rigel, JE Fischer Peptides 11 (3), 545-550, 1990 | 110 | 1990 |
| [D-TRP32] neuropeptide Y: a competitive antagonist of NPY in rat hypothalamus A Balasubramaniam, S Sheriff, ME Johnson, M Prabhakaran, Y Huang, ... Journal of medicinal chemistry 37 (6), 811-815, 1994 | 108 | 1994 |
| [D-Trp34] neuropeptide Y is a potent and selective neuropeptide Y Y5 receptor agonist with dramatic effects on food intake☆ EM Parker, A Balasubramaniam, M Guzzi, DE Mullins, BG Salisbury, ... Peptides 21 (3), 393-399, 2000 | 102 | 2000 |
| Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm A Balasubramanium, WT Chance US Patent 6,235,718, 2001 | 100 | 2001 |
| Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing rats WT Chance, A Balasubramaniam, R Dayal, J Brown, JE Fischer Life sciences 54 (24), 1869-1874, 1994 | 100 | 1994 |
| Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3′, 5′-monophosphate production in rat small intestine: structural requirements of … AL SERVIN, C ROUYER-FESSARD, A BALASUBRAMANIAM, ... Endocrinology 124 (2), 692-700, 1989 | 97 | 1989 |
| Anorexia following the systemic injection of amylin WT Chance, A Balasubramaniam, A Stallion, JE Fischer Brain research 607 (1-2), 185-188, 1993 | 91 | 1993 |
| Syntheses, structures and anorectic effects of human and rat amylin A Balasubramaniam, V Renugopalakrishnan, M Stein, JE Fischer, ... Peptides 12 (5), 919-924, 1991 | 88 | 1991 |
| Localization of a domain in apolipoprotein E with both cytostatic and cytotoxic activity MA Clay, GM Anantharamaiah, MJ Mistry, A Balasubramaniam, ... Biochemistry 34 (35), 11142-11151, 1995 | 84 | 1995 |
| Analogs of peptide YY and uses thereof A Balasubramaniam US Patent 5,604,203, 1997 | 81 | 1997 |
| Tests of adipsia and conditioned taste aversion following the intrahypothalamic injection of amylin WT Chance, A Balasubramaniam, X Chen, JE Fischer Peptides 13 (5), 961-964, 1992 | 81 | 1992 |
| Neuropeptide Y Y2 receptor in health and disease SL Parker, A Balasubramaniam British journal of pharmacology 153 (3), 420-431, 2008 | 79 | 2008 |
John Michael ConlonProfessor of Biochemistry, University of UlsterVerified email at ulster.ac.uk
